Acute hepatitis A is currently outbreaking in Korea. Although prognosis of acute hepatitis A is generally favorable, a minority of patients are accompanied by fatal complications. Severe cholestasis is one of the important causes of prolonged hospitalization in patients with acute hepatitis A. In such cases, higher chances of additional complications and increased medical costs are inevitable. We report three cases of severely cholestatic hepatitis A, who showed favorable responses to oral corticosteroids. Thirty milligram of prednisolone was initiated and tapered according to the responses. Rapid improvement was observed in all cases without side effects. We suggest that corticosteroid administration can be useful in hepatitis A patients with severe cholestasis who do not show improvement by conservative managements. Clinical trial will be needed to evaluate effectiveness of corticosteroids in these patients. (Korean J Hepatol 2010;16:329-333)
INTRODUCTION
The incidence of acute viral hepatitis A is continuously increasing in Korea recently. 1 Patients present with fever, anorexia, nausea, vomiting, or jaundice, and frequently need hospitalization. The clinical course of acute hepatitis A is usually benign, and it is known that symptomatic treatment is sufficient for recovery. 2 However, in rare cases, acute hepatitis A can be associated with serious complications which require prolonged hospitalization, and may result in death or liver transplantation. 3 Cholestatic hepatitis is one of atypical clinical manifestations of acute viral hepatitis. Although it occurs only at a rate of 0.4~0.8%, protracted symptoms of anorexia, weight loss, pruritus, and jaundice are commonly associated. 3 These clinical situations prolong the length of hospital stay, which causes increased medical expenses and social costs.
It has been presented that there had been a rapid improvement of the clinical symptoms and signs in a patient with cholestatic hepatitis A after use of steroid. 4 However, there is no detailed information on the progress of the patient.
We recently experienced three cases of acute hepatitis A with severe cholestasis, whose serum bilirubin was promptly decreased following administration of steroid. Herein, we report our cases with detailed description of clinical courses and review of literatures.
CASE REPORT
Three patients were referred to Korea University Ansan Hospital for admission under the impression of acute hepatitis.
The patients denied history of taking any medicines, excessive drinking, and presence of chronic liver disease. Serologic tests To exclude the possibility of infiltrative liver disease or small bile duct injury, liver biopsy was performed. On histopathologic examination, moderate to severe inflammatory cell infiltration was observed surrounding hepatic lobules and portal veins.
Portal or periportal fibrosis and intracellular cholestasis were also found (Fig. 1) . However there was no bile ductular lesion.
Despite long-term conservative therapy, there was no significant improvement of the clinical features with persistence of hyperbilirubinemia. We started steroid therapy for the reversal of prolonged cholestasis. Possibility of the systemic infection other than viral hepatitis A was ruled out by absence of fever, leukocytosis, any abnormalities on chest X-ray, and pyuria.
Prednisolone 30 mg was administered until serum bilirubin fell below the half level of baseline value. Thereafter, dose of steroid was tapered at intervals of two weeks and its administration was discontinued after 6-10 weeks ( Table 1) .
The more detailed clinical information of the individual cases is described on the followings. 
DISCUSSION
Hepatitis A is a self-limited disease and is not associated with chronicity. Clinical presentations are more severe with increasing age, so adults are more frequently associated with prolonged jaundice compared to children. The genotype of the viral hepatitis A is also reported to affect the severity of the cholestasis. Recently, transient elastography is being used to estimate the stages of the hepatic fibrosis in a noninvasive manner. We performed transient elastography in our patients who were in acute phase of viral hepatitis, and it was measured as high as 23.2 kPa in average. Comparing the mean value of 11.9-13.3 kPa of the peak liver stiffness in acute hepatitis A patients from the studies we reported previously, 15, 16 it is notable that the patients in the current case series showed significantly higher values.
Considering that the histopathology showed at most portal or periportal fibrosis in these patients, this marked increase of liver stiffness is thought to have a relationship with the severity of intrahepatic necroinflammation or cholestasis. It was also previously reported that the increased liver stiffness found in patients with acute hepatitis would be related to the severity of the hepatocyte swelling resulted from necroinflammatory process. 17 However, there is no report demonstrated the increase of liver stiffness in acute viral hepatitis patients with corresponding histopathologic findings to our knowledge. In this sense, our clinical cases have a great value. Liver stiffness decreased in accordance with the stabilization of bilirubin level after treatment, which is a consistent finding with our previous reports.
15 -16 There was no recurrence of hepatitis in all of our three Further placebo-controlled studies are also warranted to determine the efficacy of the steroid therapy in patients with cholestatic hepatitis who are refractory to a long-term conservative therapy.
